首页> 外国专利> NEW PEPTIDE, PRODUCTION THEREOF, DNA CODING PEPTIDE THEREOF, VECTOR COMPRISING THE GENE, HOST CELLS TRANSFORMED WITH THE VECTOR, ANTIBODY TO THE PEPTIDE AND PHARMACEUTICAL COMPOSITION CONTAINING THE PEPTIDE OR ANTIBODY

NEW PEPTIDE, PRODUCTION THEREOF, DNA CODING PEPTIDE THEREOF, VECTOR COMPRISING THE GENE, HOST CELLS TRANSFORMED WITH THE VECTOR, ANTIBODY TO THE PEPTIDE AND PHARMACEUTICAL COMPOSITION CONTAINING THE PEPTIDE OR ANTIBODY

机译:新肽,其生产,其DNA编码肽,包含基因的载体,随载体转化的宿主细胞,与该肽的抗体以及包含该肽或抗体的药物成分

摘要

PURPOSE:To provide a novel polypeptide which is produced from a human glioblastoma cell strain and has a specific amino acid sequence, thus is useful in treatment for diseases relating to growth insufficiency and anomaly proliferation of glia, neuron or hematopoietic cells or hyperergasia or hypergasia of nerve functions. CONSTITUTION:This polypeptide has a substantially pure form of amino acid sequence given in the formula or its homologues, its fragments and fragment homologues. The peptide is obtained by culturing a host cell transformed with an expression vector comprising the DNA coding the polypeptide under such conditions that the polypeptide is expressed. The dose of the polypeptide is preferably 100mum-100mg/single dose/adult.
机译:用途:提供一种由人胶质母细胞瘤细胞株产生并具有特定氨基酸序列的新型多肽,因此可用于治疗与神经胶质,神经元或造血细胞生长异常或增生异常有关的疾病。神经功能。组成:该多肽具有分子式或其同源物,其片段和片段同源物中给出的氨基酸序列的基本纯净形式。通过在表达多肽的条件下培养用包含编码该多肽的DNA的表达载体转化的宿主细胞来获得该肽。多肽的剂量优选为100μm-100mg/单剂量/成人。

著录项

  • 公开/公告号JPH08271A

    专利类型

  • 公开/公告日1996-01-09

    原文格式PDF

  • 申请/专利权人 ONO PHARMACEUT CO LTD;

    申请/专利号JP19940164860

  • 发明设计人 SHIBAYAMA SHIRO;HIRANO JUNJI;ONO HIROYUKI;

    申请日1994-06-24

  • 分类号C12N15/09;A61K38/00;A61K39/395;C07K14/52;C07K16/24;C12N1/21;C12P21/02;

  • 国家 JP

  • 入库时间 2022-08-22 03:55:11

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号